Company Profiles

driven by the PitchBook Platform

Advent Therapeutics

Description

Developer of therapies for micro-orphan applications. The company develops a prenatal, neonatal and pediatric drug for orphans to cure disorder in newborn infants in the intensive care unit (ICU).

PRIVATE

Status

Early Stage VC

Latest Deal Type

$300k

Latest Deal Amount

$420k

Total Amount Raised

1

Investors

Description

Developer of therapies for micro-orphan applications. The company develops a prenatal, neonatal and pediatric drug for orphans to cure disorder in newborn infants in the intensive care unit (ICU).

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

PA United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Advent Therapeutics's full profile, request a free trial.

    Advent Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Advent Therapeutics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Ben Franklin Technology Partners of Southeastern PennsylvaniaVenture CapitalMinority000 0000000 0000
    Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital

    Advent Therapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    David Lopez JDCo-Founder, Chief Business Officer & President
    Thomas Hofmann Ph.DChief Scientific Officer
    David Lopez JD Co-Founder, Chief Business Officer & President
    Thomas Hofmann Ph.D Chief Scientific Officer
    Request full access to PitchBook